Harvard, Kesselheim paper highlights almost 90x increase in launch prices for new drugs since 2008
With increasing clamor over rising prices and corresponding inaccessibility of certain drugs, the newest paper out of the Journal of the American Medical Association confirms price increases — and serves as a reminder of a time when the increases weren’t so steep.
The paper, “Trends in Prescription Drug Launch Prices, 2008-2021” was written by Harvard Medical School professors Aaron Kesselheim and Ben Rome, alongside research assistant Alexander Egilman. They found that the mean net price of approved drugs increased by more than 10% every year, and the launch price for new drugs increased exponentially over that same timeframe.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 147,700+ biopharma pros reading Endpoints daily — and it's free.